Not logged in Share Save
Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial Murray, Joseph A.; Wassaf, Dina; Dunn, Karen; Arora, Samir; Winkle, Peter; Stacey, Helen; Cooper, Simon; Goldstein, Kaela E.; Manchanda, Rajesh; Kontos, Stephan; Grebe, Kristie M. Share Save
Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults LeFevre, Inge; Bravo, Lulu; Folschweiller, Nicolas; Medina, Eduardo Lopez; Moreira, Edson Duarte; Nordio, Francesco; Sharma, Mayuri; Tharenos, Leslie M.; Tricou, Vianney; Watanaveeradej, Veerachai; Winkle, Peter J.; Biswal, Shibadas Share Save
Pharmacokinetics, Pharmacodynamics, and Tolerability of Olpasiran in Healthy Japanese and Non-Japanese Participants: Results from a Phase I, Single-dose, Open-label Study Sohn, Winnie; Winkle, Peter; Neutel, Joel; Wu, You; Jabari, Freeman; Terrio, Caitlin; Varrieur, Tracy; Wang, Jingying; Hellawell, Jennifer Share Save
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients Winkle, Peter; Goldsmith, Steven; Koren, Michael J.; Lepage, Serge; Hellawell, Jennifer; Trivedi, Ashit; Tsirtsonis, Kate; Abbasi, Siddique A.; Kaufman, Allegra; Troughton, Richard; Voors, Adriaan; Hulot, Jean-Sebastien; Donal, Erwan; Kazemi, Navid; Neutel, Joel Share Save
Share Save
Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease Pultz, Ingrid Swanson; Hill, Malcolm; Vitanza, Joanne M.; Wolf, Clancey; Saaby, Lasse; Liu, Tina; Winkle, Peter; Leffler, Daniel A. Share Save
Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF-06826647: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study Singh, Ravi Shankar P.; Pradhan, Vivek; Roberts, Erika S.; Scaramozza, Matthew; Kieras, Elizabeth; Gale, Jeremy D.; Peeva, Elena; Vincent, Michael S.; Banerjee, Anindita; Fensome, Andrew; Dowty, Martin E.; Winkle, Peter; Tehlirian, Christopher Share Save
Share Save
Share Save
Share Save
Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial Turner, Mark; Papadimitriou, Athanasia; Winkle, Peter; Segall, Nathan; Levin, Michael; Doust, Matthew; Johnson, Casey; Lucksinger, Gregg; Fierro, Carlos; Pickrell, Paul; Raanan, Marsha; Tricou, Vianney; Borkowski, Astrid; Wallace, Derek Share Save
Share Save
Share Save
BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial Glorieux, Francis H.; Devogelaer, Jean-Pierre; Durigova, Michaela; Goemaere, Stefan; Hemsley, Sarah; Jakob, Franz; Junker, Uwe; Ruckle, Jon; Seefried, Lothar; Winkle, Peter J. Share Save
Share Save
Share Save
Share Save
Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study Choung, R. S.; Locke, G. R., III; Francis, D. D.; Katzka, D.; Winkle, P. J.; Orr, W. C.; Crowell, M. D.; Devault, K.; Harmsen, W. S.; Zinsmeister, A. R.; Talley, N. J. Share Save
A Novel Partial 5HT3 Agonist Pumosetrag after a Standard Refluxogenic Meal Reduces Acid Reflux Events in GERD Patients: A Randomized, Double-Blind, Placebo-Controlled Pharmacodynamic Study Choung, Rok Seon; Locke, G.; Francis, Dawn; Katzka, David; Winkle, Peter; Orr, William; Crowell, Michael; DeVault, Kenneth; Harmsen, W. Scott; Zinsmeister, Alan; Talley, Nicholas Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
